The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation
Cancer Research (2007) - Comments
pubmed: 17909059  doi: 10.1158/0008-5472.can-07-0598  issn: 0008-5472  issn: 1538-7445 

Roberto R. Rosato, Jorge A. Almenara, Stefanie Coe, Steven Grant